Inactive Instrument
Auspex Pharmaceuticals Inc Stock
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 22/04/15 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 22/04/15 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 01/09/2009 |
Rod Ferguson
BRD | Director/Board Member | 69 | 01/01/2013 |
Alex Zisson
BRD | Director/Board Member | 56 | 17/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.25% | +13.72% | +52.49% | +88.86% | 62.92B | ||
| +2.87% | +4.08% | +34.66% | +75.39% | 54.32B | ||
| -1.07% | -1.79% | -18.07% | -14.36% | 22.91B | ||
| +33.86% | +30.60% | +19.14% | +502.77% | 28.73B | ||
| +11.07% | +18.64% | +53.10% | +4.81% | 21.65B | ||
| +9.03% | +9.44% | +40.62% | -19.95% | 17.76B | ||
| -3.37% | +25.85% | +213.21% | +369.13% | 16.47B | ||
| +5.91% | +11.20% | +34.57% | +679.71% | 15.48B | ||
| -7.94% | -6.74% | +38.42% | +157.52% | 13.12B | ||
| Average | +5.24% | +8.08% | +52.02% | +204.88% | 28.15B | |
| Weighted average by Cap. | +4.86% | +8.61% | +46.35% | +166.64% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















